NCT07863440 Digital Cognitive Behavioral Therapy for Gambling Disorder
| NCT ID | NCT07863440 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitas Indonesia |
| Condition | Gambling Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-11 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-11 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This pilot randomized controlled trial evaluates the feasibility, acceptability, and preliminary clinical effects of digital cognitive behavioral therapy (CBT) for adults with gambling disorder involving online gambling in Indonesia. Twenty patient-family dyads will be enrolled. Patients with gambling disorder will be randomized to receive either 12 sessions of digital CBT or 12 individualized face-to-face CBT sessions over approximately 6 weeks. Family members in the digital arm will receive six digital family-intervention sessions over 3 weeks, while family members in the comparator arm will receive the same six-session intervention in printed format. Gambling-related symptoms, urges, cognitions, psychological symptoms, depression, sleep quality, coping, readiness to change, and family-related outcomes will be assessed during treatment. Feasibility and acceptability of the digital interventions will also be evaluated.
Eligibility Criteria
Inclusion Criteria for Patients With Gambling Disorder: * Aged 18 to 59 years. * Positive screening for gambling problems using the validated Indonesian version of the South Oaks Gambling Screen (SOGS), with a score of 5 or higher. * Diagnosis of gambling disorder according to ICD-11 criteria confirmed through a psychiatric interview conducted by an addiction psychiatrist. * Willing and able to provide written informed consent. * Has one eligible affected family member who is willing to participate and provide written informed consent. * Has access to the internet and a smartphone capable of accessing the digital intervention. Exclusion Criteria for Patients With Gambling Disorder: * No history of gambling during the previous 6 months. * History of a neuropsychiatric disorder that would interfere with study participation. * Severe mental disorder or intellectual disability preventing adequate completion of study assessments or participation in CBT. * Severe agitation preventing adequate participation in CBT. * Previous pharmacological or non-pharmacological treatment specifically for gambling disorder (treatment-naive). Inclusion Criteria for Participating Family Members: * 18 years or older. * Willing and able to provide written informed consent. * Is the parent, spouse, or sibling of the participating patient with gambling disorder. * Accompanies the patient during treatment and is affected by the patient's gambling behavior. * Has access to the internet and a smartphone capable of accessing the digital intervention. Exclusion Criteria for Participating Family Members: • The associated patient withdraws from the study or otherwise becomes ineligible for continued study participation.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07863440 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Gambling Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07863440 currently recruiting?
Yes, NCT07863440 is actively recruiting participants. Contact the research team at ksiste@yahoo.com for enrollment information.
Where is the NCT07863440 trial being conducted?
This trial is being conducted at Jakarta Pusat, Indonesia.
Who is sponsoring the NCT07863440 clinical trial?
NCT07863440 is sponsored by Universitas Indonesia. The trial plans to enroll 40 participants.